Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 206

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Early treatment suppresses the development of spike‐wave epilepsy in a rat model

Open access
Blumenfeld, Hal, Klein, Joshua P., Schridde, Ulrich, Vestal, Matthew, Rice, Timothy, Khera, Davender S., Bashyal, Chhitij, Giblin, Kathryn, Paul‐Laughinghouse, Crystal, Wang, Frederick, Phadke, Anuradha, Mission, John, Agarwal, Ravi K., Englot, Dario J., Motelow, Joshua, Nersesyan, Hrachya, Waxman, Stephen G., Levin, April R.·2008·Epilepsia

Abstract

Summary: Purpose: Current treatments for epilepsy may control seizures, but have no known effects on the underlying disease. We sought to determine whether early treatment in a model of genetic epilepsy would reduce the severity of the epilepsy phenotype in adulthood. Methods: We used Wistar albino Glaxo rats of Rijswijk (WAG/Rij) rats, an established model of human absence epilepsy. Oral ethosuximide was given from age p21 to 5 months, covering the usual period in which seizures develop in this model (age ∼3 months). Two experiments were performed: (1) cortical expression of ion channels Nav1.1, Nav1.6, and HCN1 (previously shown to be dysregulated in WAG/Rij) measured by immunocytochemistry in adult treated rats; and (2) electroencephalogram (EEG) recordings to measure seizure severity at serial time points after stopping the treatment. Results: Early treatment with ethosuximide blocked changes in the expression of ion channels Nav1.1, Nav1.6, and HCN1 normally associated with epilepsy in this model. In addition, the treatment led to a persistent suppression of seizures, even after therapy was discontinued. Thus, animals treated with ethosuximide from age p21 to 5 months still had a marked suppression of seizures at age 8 months. Discussion: These findings suggest that early treatment during development may provide a new strategy for preventing epilepsy in susceptible individuals. If confirmed with other drugs and epilepsy paradigms, the availability of a model in which epileptogenesis can be controlled has important implications both for future basic studies, and human therapeutic trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1528-1167.2007.01458.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 206

Metadata

Authors
Blumenfeld, H., Klein, J. P., Schridde, U., Vestal, M., Rice, T., Khera, D. S., Bashyal, C., Giblin, K., Paul‐Laughinghouse, C., Wang, F., Phadke, A., Mission, J., Agarwal, R. K., Englot, D. J., Motelow, J., Nersesyan, H., Waxman, S. G., & Levin, A. R.
Venue
Epilepsia
Publisher
Wiley
Published
2007-12-07
Volume
49
Issue
3
Pages
400-409
ISSN
  • 0013-9580 (ISSN-L)
  • 1528-1167
OpenAlex
W2020372671
Cited by
206
References
2
FWCI
6.01
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early treatment suppresses the development of spike‐wave epilepsy in a rat model. https://app.cochat.ai/papers/10.1111/j.1528-1167.2007.01458.x
The paper
Blumenfeld, H., Klein, J. P., Schridde, U., Vestal, M., Rice, T., Khera, D. S., Bashyal, C., Giblin, K., Paul‐Laughinghouse, C., Wang, F., Phadke, A., Mission, J., Agarwal, R. K., Englot, D. J., Motelow, J., Nersesyan, H., Waxman, S. G., & Levin, A. R. (2008). Early treatment suppresses the development of spike‐wave epilepsy in a rat model. Epilepsia. https://doi.org/10.1111/j.1528-1167.2007.01458.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.